Human CXCL8/IL-8 ELISA Kit

Product Discontinued

Human CXCL8/IL-8 ELISA Kit Summary

• Standard Curve Range: 15.6 to 1000 pg/mL
• Sensitivity: 2 pg/mL
• Inter-Assay: CV% < 8.70%
• Intra-Assay: CV% < 6.30%
• Spike Recovery: 88.00%
• Sample Volume: 50 uL
• Kit Type: ELISA Kit
• Gene: CXCL8

Applications/Dilutions

• Application Notes: IL8 (Human) ELISA Kit is a sandwich enzyme immunoassay for the quantitative measurement of human IL-8/NAP-1.

Reactivity Notes

Human

Packaging, Storage & Formulations

• Storage: Storage of components varies. See protocol for specific instructions.

Notes

This product is produced by and distributed for Abnova, a company based in Taiwan.

Alternate Names for Human CXCL8/IL-8 ELISA Kit

• 3-10C
• AMCF-I
• C-X-C motif chemokine 8
• CXCL8
• CXCL8SCYB8
• Emoctakin
• GCP1
• GCP-1TSG-1
• IL8
• IL-8
• interleukin 8
• K60
• LAI
• LECT
• LUCT
• LYNAP
• MDNCF
• MDNCFb-ENAP
• member 8
• MONAP
• MONAPGCP1
• NAF
• NAP1
• NAP-1NAP1
• NCF
• Neutrophil-activating protein 1
• Protein 3-10C
• T cell chemotactic factor
• T-cell chemotactic factor
• TCF
• TSG1

Background

IL8 is a member of the CXC chemokine family. This family of small basic heparan-binding proteins are proinflammatory and primarily mediate the activation and migration of neutrophils into tissue from peripheral blood. This chemokine is one of the major mediators of the inflammatory response and is secreted by several cell types in response to an inflammatory stimulus. It functions as a chemoattractant, and is also a potent angiogenic factor. IL8 attracts neutrophils, basophils, and T-cells, but not monocytes. Cystic fibrosis (CF) is characterized by severe lung inflammation. The inflammatory process is believed to be caused by massive overproduction of the proinflammatory protein IL8, and the high levels of IL8 in the CF lung are therefore believed to be the central mechanism behind CF lung pathophysiology.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. ELISA Kits are guaranteed for 6 months from date of receipt.

Publications for CXCL8/IL-8 ELISA Kit (KA0115)(3)

Publications using KA0115

• Fernandez-Calvet A, Rodriguez-Arce I, Almagro G et al. Modulation of Haemophilus influenzae interaction with hydrophobic molecules by the VacJ/MlaA lipoprotein impacts strongly on its interplay with the airways. Sci Rep 2018-05-02 [PMID: 29720703]
• Euba B, Lopez-Lopez N, Rodriguez-Arce I et al. Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae. Sci Rep 2017-10-16 [PMID: 29038519]
• Euba B, Moleres J, Viadas C et al. Relationship between azithromycin susceptibility and administration efficacy on nontypable Haemophilus influenzae respiratory infection. Antimicrob Agents Chemother 2015-02-23 [PMID: 25712355]

FAQs for CXCL8/IL-8 ELISA Kit (KA0115). (Showing 1 - 1 of 1 FAQs).

1. wondering what the difference is between your quantikine and duo set elisas?
   • Usually the duosets do not have the entire kit such as plates and buffers, whereas the other kits are complete.

Bioinformatics

• Gene Symbol: CXCL8